7 Results for "

CDK9-IN-11

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "CDK9-IN-11" in MCE Product Catalog:

Cat. No.: HY-130852
CAS No.: 2748368-15-0
Purity:  97.02%
Research Areas:  

Cancer

CDK9-IN-11 is a potent CDK9 inhibitor. CDK9-IN-11 is the ligand for the PROTAC CDK9 Degrader-1 (HY-103628) .
loading...
    loading...
Cat. No.: HY-170978
CAS No.: 3039540-19-4
Research Areas:  

Cancer

PROTAC CDK9 degrader-11 is an orally active, selective CDK9 PROTAC degrader with a DC50 of 1.09 nM. PROTAC CDK9 degrader-11 recruits CRBN to form a ternary complex and degrades CDK9 via the ubiquitin-proteasome pathway, thereby inhibiting RNA polymerase II phosphorylation and downregulating the expression of anti-apoptotic and pro-oncogenic genes, ultimately inducing apoptosis. PROTAC CDK9 degrader-11 is suitable for research on small-cell lung cancer (SCLC) .
loading...
    loading...
Cat. No.: HY-W247437
CAS No.: 1472731-41-1
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

E3 ligase Ligand 56 is the ligand for E3 ligase Cereblon and can be used for syntheisis of PROTAC CDK9 degrader-11 (HY-170978) .
loading...
    loading...
Cat. No.: HY-170979
CAS No.: 3039540-24-1
Research Areas:  

Cancer

CDK9 ligand 3 is the ligand for CDK9 and can be used for synthesis of PROTAC degrader PROTAC CDK9 degrader-11 (HY-170978) .
loading...
    loading...
Cat. No.: HY-170980
CAS No.: 2930001-60-6
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 166 is the conjugate composed of a E3 ligase ligand and a linker. E3 Ligase Ligand-linker Conjugate 166 can be used for synthesis of PROTAC CDK9 degrader-11 (HY-170978) .
loading...
    loading...
Cat. No.: HY-182764
Target:  

CDK

Research Areas:  

Cancer

CDK11-IN-1 is an orally active cyclin-dependent kinase 11 (CDK11) inhibitor with an IC50 of 4 nM, and it exhibits high selectivity against other kinases including CDK7 and CDK9. CDK11-IN-1 inhibits tumor growth in lung cancer xenograft models. CDK11-IN-1 can be used for lung cancer research .
loading...
    loading...
Cat. No.: HY-182764A
Target:  

CDK

Research Areas:  

Cancer

CDK11-IN-1 hydrochloride is an orally active cyclin-dependent kinase 11 (CDK11) inhibitor with an IC50 of 4 nM, and it exhibits high selectivity against other kinases including CDK7 and CDK9. CDK11-IN-1 hydrochloride inhibits tumor growth in lung cancer xenograft models. CDK11-IN-1 hydrochloride can be used for lung cancer research .
loading...
    loading...